Preoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction

Description

This prospective study will investigate the effect of pre-operative Systane iLux system administration in treated cataract induced dry eye disease.

Conditions

Dry Eye Disease, Meibomian Gland Dysfunction, Cataract Senile, Dry Eye Syndromes

Talk to us

Study Overview

On this page

Study Details

Study overview

This prospective study will investigate the effect of pre-operative Systane iLux system administration in treated cataract induced dry eye disease.

The Efficacy of the Systane iLux System on Preoperative Cataract Patients on Dry Eye Disease Due to Meibomian Gland Dysfunction

Preoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction

Condition
Dry Eye Disease
Intervention / Treatment

-

Contacts and Locations

Washington

George Washington University, Washington, District of Columbia, United States, 20037

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age greater than 18 at the time of informed consent
  • * Must understand; be willing and able, and likely to fully comply with study procedures, visit schedule, and restrictions
  • * Upcoming scheduled senile cataract surgery
  • * Eyelid abnormalities
  • * Patients with active ocular infection, active ocular inflammation or history of chronic, recurrent ocular inflammation within prior 3 months
  • * Ocular surgery within the last 6 months
  • * Occlusion therapy with lacrimal or punctum plugs within the last 3 months
  • * Patients with an ocular surface abnormality that may compromise corneal integrity
  • * Patients with ocular injury or trauma, chemical burns, or limbal stem cell deficiency (within prior 3 months)
  • * Patients with cicatricial lid margin disease
  • * patients with lid surface abnormalities that affect lid function in either eye; patients with aphakia
  • * Patients with permanent makeup or tattoos on their eyelids.
  • * Previous application/administration of Systane iLux or LipiFlow treatment

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

George Washington University,

Keith Wroblewski, MD, PRINCIPAL_INVESTIGATOR, George Washington MFA

Study Record Dates

2024-12-01